Number | Date | Country | Kind |
---|---|---|---|
9820525 | Sep 1998 | GB |
Number | Name | Date | Kind |
---|---|---|---|
3792159 | Green et al. | Feb 1974 | A |
4070455 | Green et al. | Jan 1978 | A |
4258029 | Moloney et al. | Mar 1981 | A |
4912094 | Myers et al. | Mar 1990 | A |
4987237 | Myers et al. | Jan 1991 | A |
5776468 | Hauser et al. | Jul 1998 | A |
Number | Date | Country |
---|---|---|
0239400 | Aug 1994 | EP |
0182442 | Apr 1996 | EP |
1128637 | Sep 1968 | GB |
1377074 | Dec 1974 | GB |
1492973 | Nov 1977 | GB |
2220211 | Jan 1990 | GB |
WO 9216556 | Oct 1992 | WO |
WO 9634626 | Nov 1996 | WO |
WO 9844947 | Oct 1998 | WO |
WO 9910375 | Mar 1999 | WO |
WO 9916884 | Apr 1999 | WO |
WO 9964067 | Dec 1999 | WO |
WO 9966043 | Dec 1999 | WO |
Entry |
---|
Scalzo et al. J Virol. Feb. pp. 1306-1309, 1995.* |
Penney et al. Vaccine 11: 1129-1134, 1993* |
Cox et al Vaccine 15: 248-256, 1997.* |
Nixon-George et al. (1990), “The Adjuvant Effect of Stearyl Tyrosine on a Recombinant Subunit Hepatitis B Surface Antigen,” The Journal of Immunology 144(12):4798-4802. |
Sasaki et al. (1998), “Comparison of Intranasal and Intramuscular Immunization Against Human Immunodeficiency Virus Type 1 with a DNA-Monophosphoryl Lipid A Adjuvant Vaccine,” Infection and Immunity 66(2):823-826. |
Wheeler et al. (1982), “L-Tyrosine as an Immunological Adjuvant,” Int. Archs Allergy appl. Immun. 69:113-119. |